These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34503118)

  • 1. Bone Metastatic Breast Cancer: Advances in Cell Signaling and Autophagy Related Mechanisms.
    Othman A; Winogradzki M; Lee L; Tandon M; Blank A; Pratap J
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
    Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
    Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
    J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of osteoclastic activity in prostate cancer skeletal metastases.
    Keller ET
    Drugs Today (Barc); 2002 Feb; 38(2):91-102. PubMed ID: 12532187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis.
    Haider MT; Ridlmaier N; Smit DJ; Taipaleenmäki H
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells.
    Ibaragi S; Shimo T; Iwamoto M; Hassan NM; Kodama S; Isowa S; Sasaki A
    Anticancer Res; 2010 Dec; 30(12):5029-36. PubMed ID: 21187486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan.
    Kamalakar A; Washam CL; Akel NS; Allen BJ; Williams DK; Swain FL; Leitzel K; Lipton A; Gaddy D; Suva LJ
    J Bone Miner Res; 2017 Jul; 32(7):1421-1431. PubMed ID: 28370412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives.
    Infante M; Fabi A; Cognetti F; Gorini S; Caprio M; Fabbri A
    J Exp Clin Cancer Res; 2019 Jan; 38(1):12. PubMed ID: 30621730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system].
    Sheng L; Wu CY; Chen XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):684-9. PubMed ID: 21812275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
    Wang X; Che X; Yu Y; Cheng Y; Bai M; Yang Z; Guo Q; Xie X; Li D; Guo M; Hou K; Guo W; Qu X; Cao L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):221. PubMed ID: 33081836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Endosteal Niche in Breast Cancer Bone Metastasis.
    Haider MT; Smit DJ; Taipaleenmäki H
    Front Oncol; 2020; 10():335. PubMed ID: 32232008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.
    Yin JJ; Selander K; Chirgwin JM; Dallas M; Grubbs BG; Wieser R; Massagué J; Mundy GR; Guise TA
    J Clin Invest; 1999 Jan; 103(2):197-206. PubMed ID: 9916131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer and Bone Metastases: The Underlying Mechanisms.
    Wong SK; Mohamad NV; Giaze TR; Chin KY; Mohamed N; Ima-Nirwana S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.
    Page JM; Merkel AR; Ruppender NS; Guo R; Dadwal UC; Cannonier S; Basu S; Guelcher SA; Sterling JA
    Biomaterials; 2015 Sep; 64():33-44. PubMed ID: 26115412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.